We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GPCR Conference: ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’
News

GPCR Conference: ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’

GPCR Conference: ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’
News

GPCR Conference: ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GPCR Conference: ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Taking place at The Nucleus conference centre, Chesterford Research Park, Saffron Walden, UK from 22 - 23 September 2009, the new scientific conference ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’ will provide delegates with the opportunity to hear from thought leaders and share experiences within this field.

Keynote speaker Fiona Marshall, Chief Scientific Officer, Heptares Therapeutics, will talk about “Structure-based Drug Discovery for GPCR Targets”.

The meeting will highlight the latest technological developments and tools available for drug discovery on GPCR receptors, with key opinion leaders presenting their experience of generating high-quality screening data.

Furthermore, case studies will be described where flexible assay formats and newly available tools have enhanced throughput for successful compound screening.

This meeting is being sponsored by three pioneering companies in GPCR research, BioFocus DPI, DiscoveRx and MDS Analytical Technologies.
Advertisement